Cumberland pharmaceuticals inc stock
WebApr 11, 2024 · CUMBERLAND PHARMACEUTICALS INC. : CPIX Stock Price US2307701092 MarketScreener Homepage Equities United States Nasdaq Cumberland Pharmaceuticals Inc. Summary CPIX US2307701092 CUMBERLAND PHARMACEUTICALS INC. (CPIX) Add to my list Report Summary Quotes Charts News …
Cumberland pharmaceuticals inc stock
Did you know?
WebMar 24, 2024 · Cumberland Pharmaceuticals, Inc. does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Cumberland Pharmaceuticals, Inc.’s trailing 12-month revenue is $41.2 million with a -16.9% profit margin. Year-over-year quarterly sales growth most recently was 40.7%. There are not analysts providing … WebCumberland Pharmaceuticals Inc. 1600 West End Avenue, Suite 1300 Nashville, TN 37203 Phone: (615) 255-0068 Toll Free: (877) 484-2700 Fax: (615) 255-0094. …
WebApr 11, 2024 · 54,9%. More Financials. Company. Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, … WebCumberland Pharmaceuticals Inc. (CPIX) NasdaqGS - NasdaqGS Delayed Price. Currency in USD. Follow. 2W 10W 9M. 1.9500 +0.0050 (+0.26%) At close: 04:00PM …
Web1. Grant of Option. Cumberland Pharmaceuticals Inc. (the “Company”), a Tennessee corporation, hereby grants to the Participant an option (the “Option”) to purchase from the Company up to the number of shares of common stock in the Company (the “Shares”) described in the attached Notice of Stock Option Grant (the “Notice”). WebAug 9, 2024 · NASHVILLE, Tenn., Aug. 9, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ), a specialty pharmaceutical company, today announced that its product portfolio of FDA-approved ...
WebCumberland Pharmaceuticals Inc. (the “Company”), a Tennessee corporation, hereby grants to the Participant an option (the “Option”) to purchase from the Company up to the number of shares of common stock (the “Shares”) described in the attached Notice of Stock Option Grant (the “Notice”).
WebCUMBERLAND PHARMACEUTICALS INC. STOCK OPTION AGREEMENT This Option Agreement is entered into and effective on , by and between Cumberland Pharmaceuticals Inc., a Tennessee corporation (the “Company”), and (the “Participant”). glynn insurance walthamWeb3.1 The Company may issue up to 125,000 shares of Stock, subject to the adjustment provisions of Section 8, in Awards granted hereunder. Such shares may be either authorized but unissued shares or shares issued and thereafter acquired by the Company. glynn internationalWebThe purpose of the Cumberland Pharmaceuticals Inc. 2007 Directors’ Incentive Plan is to promote the interests of the Company and its shareholders by strengthening the … glynnis anne buckleyWebMar 24, 2024 · BOSTON (MarketWatch) -- Cumberland Pharmaceuticals shares dropped in pre-market trading after the specialty drug maker issued a sales forecast that came in … glynnis andrea liebWebOur gross margins remained attractive, resulting in $8.5 million in cash generated from operations. Our balance sheet remained strong as we ended the year with $93 million in total assets – including $20 million in cash, $57 million in liabilities and $36 million of shareholders’ equity. bollywood art projectWebMar 24, 2024 · Cumberland Pharmaceuticals, Inc. does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Cumberland Pharmaceuticals, Inc.’s … glynn iron recyclingWeb1. Grant of Option.Cumberland Pharmaceuticals Inc. (the “Company”), a Tennessee corporation, hereby grants to the Participant an option (the “Option”) to purchase from the Company up to the number of shares of common stock in the Company (the “Shares”) described in the attached Notice of Stock Option Grant (the “Notice”). bollywood art movies